No More Needles! Orbis Unveils Groundbreaking Oral Peptide Drugs
In a bid to revolutionize the landscape of biologic drugs, Orbis Medicines has emerged from stealth mode with a promising solution – oral peptide therapies. In a bid to revolutionize…
In a bid to revolutionize the landscape of biologic drugs, Orbis Medicines has emerged from stealth mode with a promising solution – oral peptide therapies. In a bid to revolutionize…
Omalizumab has been greenlit for the reduction of allergic reactions, including potentially life-threatening anaphylaxis, stemming from accidental exposure to various food allergens. The Food and Drug Administration’s recent approval of…
The identification of low-abundance monoclonal antibodies within diverse polyclonal populations holds immense value across clinical and research domains. In a groundbreaking development for the fields of disease diagnostics, vaccine development,…
Arialys Therapeutics has secured $58 million in seed funding for the development of treatments targeting autoimmune neuropsychiatric diseases. Arialys Therapeutics, a pioneering force in neurological advancements, has secured $58 million…
This groundbreaking partnership signifies a monumental leap forward in the pursuit of innovative and curative treatments for a range of ocular diseases. Otsuka Pharmaceutical has embarked on an ambitious, multi-target…
Acquired Immune Deficiency Syndrome (AIDS), hepatitis B, and C outbreaks are a possibility in the overcrowded 42 Punjab prisons. Acquired Immune Deficiency Syndrome (AIDS), hepatitis B, and C outbreaks are…
In spite of the tragedies of 2020, man-made brainpower has revived its encouraging. Baidu increased its exhibition across antibodies, self-ruling vehicles, language preparing, and quantum registering.
Australian researchers are working on a coronavirus antibody program that could treat and prevent COVID-19, especially among the elderly and vulnerable. Associate Professor Wai-Hong Tham, from Walter and Eliza Hall…
Since its founding in 2014, Axim Biotechnologies Inc (OTCMKTS:AXIM) has been steering the wheels of discovery and development of advanced and targeted small molecule and monoclonal antibody therapies. The company…
Product developed by Sinopharm and Wuhan Institute of Biological Products An inactivated Covid-19 vaccine candidate developed by Chinese scientists produced a robust immune response and mild side effects in early…
Scientist Discovers A Very Potent Covid-19 Antibody Mix Treatment : Researchers have identified a potent cocktail of antibodies that may help doctors treat Covid-19 infections and protect people at risk…
These tests look for the presence of antibodies, which are proteins made in response to COVID-19 infection. Antibodies are detected in the blood of people who are tested after infection;…